Coltac Therapeutics
PrivateLast Round
Seed
Apr 1, 2022
Company Overview
Coltac Therapeutics is a biotechnology company that develops a proprietary bacteria-based screening platform for the discovery of novel molecular glues for targeted protein degradation in oncology and other therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coltac Therapeutics Comparables
Compare Coltac Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TenAces Biosciences | 89% | |
| Magnet Biomedicine | 85% | |
| Degron Therapeutics | 85% |
Coltac Therapeutics Funding Rounds
Historical fundraising activity
Coltac Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Seed |
| aMoon | Seed |
| Ramot at Tel Aviv University | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2025
Grew 43% QoQ from 7 to 10 employees.
Coltac Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Coltac Therapeutics's valuation, stock price, and market status.
Is Coltac Therapeutics a public or private company?
Coltac Therapeutics is a private company.
What is the current stock price of Coltac Therapeutics?
Coltac Therapeutics is a private company, so its shares have no public market price. Caplight tracks Coltac Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Coltac Therapeutics worth (valuation)?
Valuation information for Coltac Therapeutics is not publicly available.
Can I buy Coltac Therapeutics stock?
Coltac Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Coltac Therapeutics's last funding round?
Coltac Therapeutics's most recent funding round was Seed on April 1, 2022.
Who are the main investors in Coltac Therapeutics?
Key investors in Coltac Therapeutics include Israel Biotech Fund, aMoon, Ramot at Tel Aviv University.
Will Coltac Therapeutics IPO soon?
No public IPO plans have been announced for Coltac Therapeutics.
How can I track Coltac Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Coltac Therapeutics's shares on secondary markets.